Ultimele actualizari :
29/10/2024
Imunosupresor   Adalimumab  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abrilada Argentina
Amgevita Belgia, Chilli, Franta, Germania, Marea Britanie
Hadlima Australia
Hulio Germania
Humira Arabia Saudita, Argentina, Australia, Austria, Belgia, Brazilia, Canada, Chilli, Columbia, Danemarca, Ecuador, Elvetia, Emiratele Arabe Unite, Finlanda, Franta, Germania, Grecia, Islanda, Italia, Japonia, Marea Britanie, Mexic, Norvegia, noua Zeelandă, Olanda, Peru, Polonia, Portugalia, Romania, Spania, SUA, Suedia, Turcia, Venezuela
Hyrimoz Brazilia, Ecuador, Slovenia
Imraldi Belgia, Marea Britanie, Slovenia, Spania
Truxeda Austria, Belgia, Danemarca, Finlanda, Germania, Grecia, Islanda, Japonia, Polonia, Suedia
Bibliografie   Injectabil   Bibliografie : Adalimumab  
tip publicare
4627 ziar Park D, Yun J, Hwang S-J, Park SJ.
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Adv Ther 2019 36:442–450
4644 ziar Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A.
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Adv Ther 2021 ; 38 : 5609–5622

  Mentions Légales